SCHEMBL7466588

SCHEMBL7466588

CN(C)CCCN1CCN(/N=C/c2ccccc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.38
LMNA P02545 5/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPK1 P28482 3/20 0.38
GFER P55789 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
MAOB P27338 1/20 0.37
NR1I2 O75469 1/20 0.36
POLB P06746 1/20 0.36
AHR P35869 1/20 0.36
RAD52 P43351 1/20 0.36
RCE1 Q9Y256 1/20 0.36
MAPT P10636 5/20 0.36
HRH1 P35367 2/20 0.36
HTR3E A5X5Y0 1/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
CACNA1F O60840 1/20 0.36
SLC22A3 O75751 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7457200 1.00 SMN1; SMN2 (0.38) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7464168 0.96 BCHE (0.41) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7456178 0.96 BCHE (0.41) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7455507 0.92 MAPT (0.40) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7461319 0.92 MAPT (0.40) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7461037 0.82 SMN1; SMN2 (0.37) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7458035 0.82 GAA (0.40) SMN1; SMN2LMNAALDH1A1MAPK1BCHE
SCHEMBL7458042 0.82 GAA (0.40) SMN1; SMN2LMNAALDH1A1MAPK1BCHE
SCHEMBL7461047 0.82 SMN1; SMN2 (0.37) SMN1; SMN2LMNAALDH1A1MAPK1GFER
SCHEMBL7456570 0.81 SIGMAR1 (0.48) SMN1; SMN2LMNAALDH1A1MAPK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891976-B1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents PROCTER & GAMBLE PHARMA (US) 2002-10-16 EP disclosed
US-6083945-A USEFUL IN TREATING HUMANS OR OTHER MAMMALS WITH CARDIAC ARRHYTHMIA AND/OR CARDIAC FIBRILLATION THE PROCTER & GAMBLE COMPANY (US) 2000-07-04 US disclosed
EP-0598046-B1 CYCLIC UREAS USEFUL AS ANTIARRHYTHMIC AND ANTIFIBRILLATORY AGENTS PROCTER & GAMBLE PHARMA (US) 1999-03-24 EP disclosed
EP-0891976-A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents PROCTER & GAMBLE PHARMACEUTICALS (US) 1999-01-20 EP disclosed